Selvadministreret

Selvadministreret refers to treatments or therapies that patients administer themselves outside direct professional supervision, after receiving appropriate training and safeguards. It encompasses a range of interventions that can be carried out at home or in non-clinical settings, often under prescription and with prescribed equipment or devices.

Common domains include injectable medications (such as insulin for diabetes, hormones for certain conditions, or biologics for autoimmune diseases), oral medications for chronic conditions, and the use of home devices like glucose monitors, inhalers, or epinephrine auto-injectors. In many cases, self-administration is supported by standardized instructions, patient education, and access to healthcare support if problems arise.

Benefits of selvadministreret care include greater autonomy for patients, increased convenience, reduced need for frequent clinic visits, potential cost savings, and the possibility of improved adherence when routines are easier to integrate into daily life. It can also expand access to treatment for people in remote or underserved areas.

Risks and challenges include the potential for incorrect technique, dosing errors, improper storage or handling of medications, device malfunctions, and delays in seeking professional help for adverse effects. Successful self-administration relies on adequate training, literacy, dexterity, and ongoing support, as well as robust systems for monitoring safety and outcomes.

Regulatory and practice considerations vary by jurisdiction but commonly require prescriber authorization, documented training, written or digital instructions, and mechanisms for reporting adverse events. Implementation often involves patient selection criteria, teach-back training methods, follow-up assessments, and the use of telemedicine or digital tools to support monitoring and safety.